韦尔斯和艾森伯格就《他汀类药物用于高敏C反应蛋白升高或血脂异常女性心血管事件一级预防：来自他汀类药物预防的理由：一项评估瑞舒伐他汀的干预试验（JUPITER）及一级预防试验女性荟萃分析》一文所写的信函 - Suppr | 超能文献

Letter by Wells and Eisenberg regarding article, "Statins for the primary prevention of cardiovascular events in women with elevated high-sensitivity C-reactive protein or dyslipidemia: results from the Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) and meta-analysis of women from primary prevention trials".

作者信息

Wells Martin T, Eisenberg Theodore

出版信息

Circulation. 2010 Dec 7;122(23):e575; author reply e577. doi: 10.1161/CIRCULATIONAHA.110.953216.

DOI:10.1161/CIRCULATIONAHA.110.953216

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Letter by Wells and Eisenberg regarding article, "Statins for the primary prevention of cardiovascular events in women with elevated high-sensitivity C-reactive protein or dyslipidemia: results from the Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) and meta-analysis of women from primary prevention trials".韦尔斯和艾森伯格就《他汀类药物用于高敏C反应蛋白升高或血脂异常女性心血管事件一级预防：来自他汀类药物预防的理由：一项评估瑞舒伐他汀的干预试验（JUPITER）及一级预防试验女性荟萃分析》一文所写的信函

Circulation. 2010 Dec 7;122(23):e575; author reply e577. doi: 10.1161/CIRCULATIONAHA.110.953216.

2

Letter by Vos et al regarding article, "Statins for the primary prevention of cardiovascular events in women with elevated high-sensitivity C-reactive protein or dyslipidemia: results from the Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) and meta-analysis of women from primary prevention trials".沃斯等人就文章《他汀类药物用于高敏C反应蛋白升高或血脂异常女性心血管事件一级预防：来自他汀类药物在预防中的应用理由：一项评估瑞舒伐他汀的干预试验（JUPITER）及一级预防试验女性荟萃分析的结果》所写的信。

Circulation. 2010 Dec 7;122(23):e576; author reply e577. doi: 10.1161/CIRCULATIONAHA.110.954016.

3

Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention?他汀类药物用于一级预防的理由：一项评估瑞舒伐他汀的干预试验（JUPITER）——C反应蛋白能否用于指导一级预防中的他汀类药物治疗？

Am J Cardiol. 2006 Jan 16;97(2A):33A-41A. doi: 10.1016/j.amjcard.2005.11.014. Epub 2005 Dec 1.

4

Number needed to treat with rosuvastatin to prevent first cardiovascular events and death among men and women with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin (JUPITER).在低密度脂蛋白胆固醇水平低且高敏C反应蛋白升高的男性和女性中，使用瑞舒伐他汀预防首次心血管事件和死亡的需治疗人数：他汀类药物用于预防的依据：一项评估瑞舒伐他汀的干预试验（JUPITER）

Circ Cardiovasc Qual Outcomes. 2009 Nov;2(6):616-23. doi: 10.1161/CIRCOUTCOMES.109.848473. Epub 2009 Sep 22.

5

Prevalence of low low-density lipoprotein cholesterol with elevated high sensitivity C-reactive protein in the U.S.: implications of the JUPITER (Justification for the Use of Statins in Primary Prevention: An Intervention Trial Evaluating Rosuvastatin) study.美国低密度脂蛋白胆固醇水平低且高敏C反应蛋白升高的患病率：JUPITER（他汀类药物在一级预防中的应用：评估瑞舒伐他汀的干预试验）研究的启示

J Am Coll Cardiol. 2009 Mar 17;53(11):931-5. doi: 10.1016/j.jacc.2008.12.010.

6

The gravity of JUPITER (Justification for the Use of Statins in Primary Prevention: An Intervention Trial Evaluating Rosuvastatin).JUPITER研究（他汀类药物在一级预防中的应用理由：一项评估瑞舒伐他汀的干预试验）

Postgrad Med. 2009 May;121(3):113-8. doi: 10.3810/pgm.2009.05.2010.

7

Primary prevention of vascular events in patients with high levels of C-reactive protein: the JUPITER study.高C反应蛋白水平患者血管事件的一级预防：JUPITER研究

Expert Rev Cardiovasc Ther. 2009 Sep;7(9):1041-56. doi: 10.1586/erc.09.93.

8

Another look at the results of the JUPITER trial.再看 JUPITER 试验的结果。

Am J Cardiol. 2009 Dec 1;104(11):1603-5. doi: 10.1016/j.amjcard.2009.07.033. Epub 2009 Oct 14.

9

The JUPITER trial: How will it change clinical practice?JUPITER试验：它将如何改变临床实践？

Rev Cardiovasc Med. 2009 Spring;10(2):91-6.

10

Statins for the primary prevention of cardiovascular events in women with elevated high-sensitivity C-reactive protein or dyslipidemia: results from the Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) and meta-analysis of women from primary prevention trials.对于高敏 C 反应蛋白升高或血脂异常的女性，用他汀类药物进行心血管一级预防：来自评估瑞舒伐他汀用于预防的应用（JUPITER）的干预试验和来自一级预防试验的女性亚组的荟萃分析的结果。

Circulation. 2010 Mar 9;121(9):1069-77. doi: 10.1161/CIRCULATIONAHA.109.906479. Epub 2010 Feb 22.